New appointment at Synexus
This article was originally published in Scrip
The UK-based CRO Synexus has appointed Alison Martin vice-president of international projects. She was previously vice-president of clinical development in the cardiovascular and endocrine therapeutic area at INC Research. In her new role, she will be responsible for the creation of a management service to support the company's growth strategy.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.